GNG11 and non-small cell lung carcinoma: We have concluded that chemokine signaling pathway and GNG11–chemokine interactions may provide more promising drug targets for NSCLC from three levels of analysis: (1) the functional enrichment analysis showed that module 2 was functionally enriched for tumor-related signal transduction pathways, especially chemokine signaling.